As of Nov 27
| -0.06 / -1.19%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 5.50. The median estimate represents a +60.32% increase from the last price of 4.99.
The current consensus among 5 polled investment analysts is to Buy stock in Genesis Healthcare Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.